Affinity Engineering Modulates Soluble Antigen Degrader Activity.

Authors

Itay Algov, Lawrence Shue, Xin Zhou

Published in

Chembiochem : a European journal of chemical biology. Volume 27. Issue 20. Pages e70549. Oct 28, 2026.

Abstract

Soluble extracellular proteins drive many physiological and pathological signaling pathways, and targeted degradation offers a potential strategy for their therapeutic modulation. Here, we engineered bispecific targeting chimeras (TACs) that couple soluble proteins to constitutively internalizing cell-surface effectors for clearance. Using transferrin receptor 1 (TfR1) as an initial effector, we find that uptake depends on both binding arms. Rapid target association facilitates extracellular antigen capture, while increased intracellular dissociation can improve uptake when overall binding strength is maintained. Introducing pH-sensitive target binders enhances internalization, but only when neutral-pH affinity remains high. We also find that atypical chemokine receptor 5 (ACKR5) can serve as an alternative internalizing effector. Applying these principles to tumor necrosis factor-alpha (TNF-α), an optimized TAC more effectively inhibits its signaling than FDA-approved anti-TNF-α therapy adalimumab. These findings identified molecular determinants for engineering TACs targeting soluble extracellular proteins.

PMID:
42900781
Bibliographic data and abstract were imported from PubMed on 21 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.